Renal function tests on diabetes-induced and non-induced APA hamsters

Experimental Animals

Volumn 51, Issue 5, 2002, Pages 437-445

  Inenaga, Toshiaki ^a,b   Nishida, Etsuko ^a   Kawamura, Seiji ^a   Yoshikawa, Yasuhiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

APA hamsters; Diabetic nephropathy; Model animal; Renal function tests

Indexed keywords

ANIMAL; ARTICLE; DIABETIC NEPHROPATHY; DISEASE MODEL; EXPERIMENTAL DIABETES MELLITUS; HAMSTER; HUMAN; KIDNEY; KIDNEY FUNCTION TEST; MALE; PATHOLOGY; PATHOPHYSIOLOGY; SYRIAN HAMSTER;

ANIMALS; CRICETINAE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MESOCRICETUS;

ANIMALIA; CRICETINAE; MESOCRICETUS AURATUS;

EID: 0041370250     PISSN: 13411357     EISSN: None     Source Type: Journal    
DOI: 10.1538/expanim.51.437     Document Type: Article

References (50)

1. Aguirre, J.I., Han, J.S., Itagaki, S., and Doi, K. 1993. Lectin histochemical study on the kidney of normal and streptozotocin-induced diabetic hamsters. Histol. Histopathol. 8: 273-278.
2. Baynes, J. and Thorpe, S. 1999. Role of oxidative stress in diabetic complications. Diabetes 48: 1-9.
3. Davis, F. and Davis, P. 1981. Water metabolism in diabetes mellitus. Am. J. Med. 70: 211-214.
4. Ding, G., Goor, H., Ricardo, S., Orlowski, J., and Diamond, J. 1997. Oxidized LDL stimulates the expression of TGF-beta and fibronectin in human glomerular epitherial cells. Kidney Int. 51: 147-154.
5. Doi, K., Yamamoto, T., Isegawa, N., Doi, C., and Mitsuoka, T. 1987. Age-related non-neoplastic lesions in the heart and kidneys of Syrian hamsters of the APA strain. Lab. Anim. 21: 241-248.
6. Feehally, J., Taverner, D., Burden, A., and Walls, J. 1983. Predictors of renal function in diabetic and non-diabetic renal disease. Clin. Chim. Acta. 133: 169-175.
7. Fioretto, P., Steffes, M., Sutherland, D., and Mauer, M. 1995. Sequential renal biopsies in insulin-dependent diabetic patients: structural factors associated with clinical progression. Kidney Int. 48: 1929-1935.
8. Flyvberg, A. 2000. Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease. Diabetologia 43: 1205-1223.
9. Friedman, R., Azevedo, M., and Gross, J. 1991. Am. J. Kidney Dis. 17: 725-726.
10. Furuta, T., Saito, T., Ootaka, T., Soma, J., Obara, K., Abe, K., and Yoshinaga, K. 1993. The role of macrophages in diabetic glomerulosclerosis. Am. J. Kidney Dis. 21: 480-485.
11. Gennari, F. and Kassirer, J. 1974. Osmotic diuresis. N. Engl. J. Med. 291: 714-720.
12. Han, J.S., Norimatsu, M., Itagaki, S., and Doi, K. 1992. Early development of spontaneous glomerular lesion in Syrian hamsters of APA strain. J. Vet. Med. Sci. 54: 149-151.
13. Han, J.S., Norimatsu, M., Sugawara, Y., and Doi, K. 1990. Acute toxicity of streptozotocin in Syrian hamsters of the APA strain. J. Toxicol. Pathol. 3: 189-199.
14. Han, J.S., Sugawara, Y., and Doi, K. 1992. Rapid induction of glomerular lipidosis in APA hamsters by streptozotocin. Int. J. Exp. Pathol. 73: 75-84.
15. Hommel, E., Andersen, P., Gall, M., Nielsen, F., Jensen, B., Rossing, P., Dyerberg, J., and Parving, H. 1992. Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy. Diabetologia 35: 447-451.
16. Hostetter, T., Rennke, H., and Brenner, B. 1982. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am. J. Med. 72: 375-380.
17. Inman, S., Stowe, N., Cressman, M., Brouhard, B., Nally, J., Satoh, S., Satodate, R., and Vidt, D. 1999. Lovastatin preserves renal function in experimental diabetes. Am. J. Med. Sci. 317: 215-221.
18. Kamanna, V., Pai, R., Ha, H., Kirschenbaum, M., and Roh, D. 1999. Oxidized low-density lipoprotein stimulates monocyte adhesion to glomerular endothelial cells. Kidney Int. 55: 2192-2202.
19. Kikkawa, R. and Haneda, M. 1997. Pathogenesis of diabetic nephropathy. Clin. Exp. Nephrol. 1: 3-11.
20. Kramer-Guth, A., Quaschning, T., Greiber, S., and Wanner, C. 1996. Potential role of lipids in the progression of diabetic nephropathy. Clin. Nephrol. 46: 262-265.
21. Lam, K., Cheng, I., Janus, E., and Pang, R. 1995. Cholesterol-lowering therapy may retard the progresion of diabetic nephropathy. Diabetologia 38: 604-609.
22. Lee, H., Kim, B., Kim, Y., Choi, K., and Chung, H. 1996. Involvement of oxidation in LDL-induced collagen gene regulation in mesangial cells. Kidney Int. 50: 1582-1590.
23. Maguire, S., Hamilton, J., and Fulker, M. 1974. A spontaneous glomerular lesion in the Syrian hamster (Mesocricetus auratus). Br. J. Exp. Pathol. 55: 562-569.
24. Mauer, S., Steffes, M., Ellis, E., Sutherland, D., Brown, D., and Goetz, F. 1984. Structural-functional relationships in diabetic nephropathy. J. Clin. Invest. 74: 1143-1155.
25. Mogensen, C. 1986. Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathy. Scand. J. Clin. Lab. Invest. 46: 201-206.
26. Mogensen, C. 1994. Glomerular hyperfiltration in human diabetes. Diabetes Care 17: 770-775.
27. Mogensen, C. and Christensen, C. 1984. Predicting diabetic nephropathy in insulin-dependent patients. N. Engl. J. Med. 311: 89-93.
28. Nakamura, T., Fukui, M., Ebihara, I., Osada, S., Nagaoka, I., Tomino, Y., and Koide, H. 1993. mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes 42: 450-456.
29. Nishida, E., Yamanouchi, J., Ogata, S., Itagaki, S., and Doi, K. 1996. Age-related histochemical and ultrastructural changes in renal glomerular mesangium of APA hamsters. Exp. Anim. 45: 339-345.
30. Nishida, E., Yamanouchi, J., Ogata, S., Doi, K., and Itagaki, S. 1997. Modification of spontaneous renal lesion of APA hamsters by streptozotocin-induced diabetes. Int. J. Exp. Pathol. 78: 169-176.
31. Norden, G., Bjorck, S., Granerus, G., and Nyberg, G. 1987. Estimation of renal function in diabetic nephropathy. Nephron 47: 36-42.
32. Onoue, M., Uchida, K., Takahashi, T., Kusano, N., and Mutai, M. 1978. Relationship between some biochemical mesurements and histopathological changes in age-related kidney lesions of rats. Jikken Dobutsu 27: 405-412.
33. Østerby, R. 1992. Glomerular structural changes in type 1 (insulin-dependent) diabetes mellitus: causes, consequences, and prevention. Diabetologia 35: 803-812.
34. Parving, H.-H., Andersen, A., and Smidt, U. 1985. Monitoring progression of diabetic nephropathy. Ups. J. Med. Sci. 90: 15-23.
35. Pfeiffer, A. and Schatz, H. 1995. Diabetic microvascular complications and growth factors. Exp. Clin. Endocrinol. Diabetes. 103: 7-14.
36. Rudberg, S., Persson, B., and Dahlquist, G. 1992. Increased glomerular filtration rate as a predictor of diabetic nephropathy. Kidney Int. 41: 822-828.
37. Sanai, T., Sobka, T., Johnson, T., El-Essawy, M., Muchaneta-Kubara, E., Gharbia, O., Oldroyd, S., and Nahas, A. 2000. Expression of cytoskeletal proteins during the course of experimental diabetic nephropathy. Diabetologia 43: 91-100.
38. Sasaki, T., Kurata, H., Nomura, K., Utsunomiya, K., and Ikeda, Y. 1990. Amelioration of proteinuria with pravastatin in hyoercholesterolemic patients with diabetes mellitus. Jpn. J. Med. 29: 156-163.
39. Shoji, T., Nishizawa, Y., Toyokawa, A., Kawagishi, T., Okuno, Y., and Morii, H. 1991. Decreased albumiuria by pravastatin in hyperlipidemic diabetes. Nephron 59: 664-665.
40. Steffes, M. and Mauer, S. 1984. Diabetic glomerulopathy in man and experimental animal models. Int. Rev. Exp. Pathol. 26: 147-175.
41. Sterzel, R., Schulze-Lohoff, E., and Marx, M. 1993. Cytokines and mesangial cells. Kidney Int. 43: S26-S31.
42. Tanaka, S., Nozaki, M., Maruyamauchi, T., Kaneko, T., Yamanouchi, K., Okugi, M., and Matsuzawa, A. 1988. Laboratory strains of hamster, gerbil and mastomys maintained at the Institute of Medical Science, University of Tokyo. Jpn. J. Exp. Med. 58: 276-278.
43. Tonolo, G., Ciccarese, M., Brizzi, P., Puddu, L., Secchi, G., Calva, P., Atzeni, M., Melis, M., and Maioli, M. 1997. Reduction of albumin excretion rate in normotensive microalbumiuric type 2 diabetic patients during long-term simvastatin treatment. Diabetes Care 20: 1891-1895.
44. Walczyk, M., Pulliam, J., and Bennett, W. 1990. Effects of hyperglycemia and mannitol infusions on renal hemodynamics in normal subjects. Am. J. Med. Sci. 300: 218-224.
45. Wang, S., LaPage, J., and Hirschberg, R. 2000. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy. Kidney Int. 57: 1002-1014.
46. Witztum, J. and Steinberg, D. 1991. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88: 1785-1792.
47. Yamanouchi, J., Nishida, E., Itagaki, S., Kawamura, S., Doi, K., and Yoshikawa, Y. 2000. Aortic atheromatous lesions developed in APA hamsters with streptozotocin induced diabetes: A new animal model for diabetic atherosclerosis. 1. Histopathological studies. Exp. Anim. 49: 259-266.
48. Yamanouchi, J., Sugawara, Y., Itagaki, S., and Doi, K. 1995. Age-related changes of aorta in Syrian hamsters of APA strain. Histol. Histopathol. 10: 703-708.
49. Yamanouchi, J., Takatori, A., Itagaki, S., Kawamura, S., and Yoshikawa, Y. 2000. APA hamster model for diabetic atherosclerosis. 2. Analysis of lipids and lipoproteins. Exp. Anim. 49: 267-274.
50. Yaqoob, M., McClelland, P., Patrick, A., Stevenson, A., Mason, H., and Bell, G. 1994.Tubulopathy with macroalbuminuria due to diabetic nephropathy and primary glomerulonephritis. Kidney Int. 46: S101-S104.